Dow Up 0.00% Nasdaq Up 0.09%

Portola Pharmaceuticals, Inc. (PTLA)

-NasdaqGS
28.12 Down 0.80(2.77%) Nov 28, 1:00PM EST
Prev Close:28.92
Open:29.07
Bid:1.00 x 100
Ask:N/A
1y Target Est:39.00
Beta:-2.723
Earnings Date:Feb 25 - Mar 2 (Est.)
Day's Range:28.02 - 29.07
52wk Range:19.59 - 31.48
Volume:131,617
Avg Vol (3m):366,505
Market Cap:1.37B
P/E (ttm):N/A
EPS (ttm):-3.01
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for PTLA

Comparison

Symbol% ChgMkt Cap
PTLADown 2.77%1.37B
BAYRYUp 1.86%124.10B
PFEUp 0.16%196.27B
SNYUp 0.42%126.72B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):151.72
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-3.27
Quarterly EPS Est (Dec-14) :-0.90
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Portola Pharmaceuticals, Inc., a biopharmaceutical company, develops product candidates in the fields of thrombosis and hematology. Its lead compound, Betrixaban, is an oral, once-daily Factor Xa inhibitor in Phase III study for hospital to home p... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback